Common liability to addiction and "gateway hypothesis": Theoretical, empirical and evolutionary perspective

Drug and Alcohol Dependence

Volumn 123, Issue SUPPL.1, 2012, Pages

  Vanyukov, Michael M ^a,b   Tarter, Ralph E ^a,b   Kirillova, Galina P ^a   Kirisci, Levent ^a   Reynolds, Maureen D ^a   Kreek, Mary Jeanne ^c   Conway, Kevin P ^d   Maher, Brion S ^e   Iacono, William G ^f   Bierut, Laura ^g   Neale, Michael C ^h   Clark, Duncan B ^b   Ridenour, Ty A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug abuse; Drug dependence; Evolution; Genetics; Phenotype

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENERGIC RECEPTOR; AMPHETAMINE; BENZODIAZEPINE; CHOLINERGIC RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; HYDROCORTISONE; ILLICIT DRUG; METENKEPHALIN; NICOTINIC RECEPTOR; OPIATE RECEPTOR; OXYTOCIN; PROTEIN C FOS; SEROTONIN; VASOPRESSIN;

ANTISOCIAL BEHAVIOR; BEHAVIOR CHANGE; COGNITION; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; EMPIRICAL RESEARCH; EVOLUTIONARY ADAPTATION; GATEWAY HYPOTHESIS; GENETIC VARIABILITY; GENETICS; HUMAN; METRIC SYSTEM; ONTOGENY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; REVIEW; SOCIAL PROBLEM; SOCIALIZATION; STAGING; SUBSTANCE ABUSE; THEORETICAL STUDY; THEORY;

BEHAVIOR, ADDICTIVE; BIOLOGICAL EVOLUTION; CAUSALITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK; SOCIAL ENVIRONMENT; SUBSTANCE-RELATED DISORDERS;

EID: 84862870911     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.12.018     Document Type: Review

References (145)

1. Agrawal A., Neale M.C., Prescott C.A., Kendler K.S. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav. Genet. 2004, 34:217-228.
2. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav. Brain Res. 1999, 103:203-209.
3. Bartels M., Hudziak J.J., van den Oord E.J., van Beijsterveldt C.E., Rietveld M.J., Boomsma D.I. Co-occurrence of aggressive behavior and rule-breaking behavior at age 12: multi-rater analyses. Behav. Genet. 2003, 33:607-621.
4. Bassareo V., Di Chiara G. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J. Neurosci. 1997, 17:851-861.
5. Bauer L.O., Hesselbrock V.M. Brain maturation and subtypes of conduct disorder: interactive effects on p300 amplitude and topography in male adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2003, 42:106-115.
6. Belsky J., Steinberg L., Draper P. Childhood experience, interpersonal development, and reproductive strategy: and evolutionary theory of socialization. Child Dev. 1991, 62:647-670.
7. Boomsma D.I., de Geus E.J., van Baal G.C., Koopmans J.R. A religious upbringing reduces the influence of genetic factors on disinhibition: evidence for interaction between genotype and environment on personality. Twin Res. 1999, 2:115-125.
8. Bowlby J. Attachment and Loss 1969, Basic Books, New York.
9. Breysse N., Risterucci C., Amalric M. D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens. Pharmacol. Biochem. Behav. 2002, 73:347-357.
10. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
11. Burkett W. Greek Religion: Archaic and Classical (Ancient World) 2004, Blackwell Publishing, Boston, (Originally published in German as Griechische Religion der archaischen und klassische Epoche, in the series Die religionen der Menschheit, vol. 15 by Verlag W. Kohlhammer, Stuttgart, 1977).
12. Button T.M., Corley R.P., Rhee S.H., Hewitt J.K., Young S.E., Stallings M.C. Delinquent peer affiliation and conduct problems: a twin study. J. Abnorm. Psychol. 2007, 116:554-564.
13. Cameron J.L. Interrelationships between hormones, behavior, and affect during adolescence: understanding hormonal, physical, and brain changes occurring in association with pubertal activation of the reproductive axis. Introduction to part III. Ann. N. Y. Acad. Sci. 2004, 1021:110-123.
14. Caspi A., Lynam D., Moffitt T.E., Silva P.A. Unraveling girls' delinquency: biological, dispositional, and contextual contributions to adolescent misbehavior. Dev. Psychol. 1993, 29:19-30.
15. Clark D.B., Thatcher D.L., Tapert S.F. Alcohol, psychological dysregulation, and adolescent brain development. Alcohol. Clin. Exp. Res. 2008, 32:375-385.
16. Compton W.M., Thomas Y.F., Conway K.P., Colliver J.D. Developments in the epidemiology of drug use and drug use disorders. Am. J. Psychiatry 2005, 162:1494-1502.
17. Conway K.P., Levy J., Vanyukov M., Chandler R., Rutter J., Swan G.E., Neale M. Measuring addiction propensity and severity: the need for a new instrument. Drug Alcohol Depend. 2010, 111:4-12.
18. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Ohnishi Y.N., Berton O., Fass D.M., Renthal W., Rush A.J., Wu E.Y., Ghose S., Krishnan V., Russo S.J., Tamminga C., Haggarty S.J., Nestler E.J. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 2009, 29:11451-11460.
19. Darwin C. The Descent of Man, and Selection in Relation to Sex 1871, John Murray, London.
20. Das S., Grunert M., Williams L., Vincent S.R. NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 1997, 25:227-233.
21. Dawson D.A., Grant B.F., Stinson F.S. Maturing out of alcohol dependence: The impact of transitional life events. J. Stud. Alcohol 2006, 67:195-203.
22. De Dreu C.K., Greer L.L., Handgraaf M.J., Shalvi S., Van Kleef G.A., Baas M., Ten Velden F.S., Van Dijk E., Feith S.W. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 2010, 328:1408-1411.
23. Degenhardt L., Dierker L., Chiu W.T., Medina-Mora M.E., Neumark Y., Sampson N., Alonso J., Angermeyer M., Anthony J.C., Bruffaerts R., de Girolamo G., de Graaf R., Gureje O., Karam A.N., Kostyuchenko S., Lee S., Lepine J.P., Levinson D., Nakamura Y., Posada-Villa J., Stein D., Wells J.E., Kessler R.C. Evaluating the drug use gateway theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend. 2010, 108:84-97.
24. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
25. Dishion T.J., Nelson S.E., Bullock B.M. Premature adolescent autonomy: parent disengagement and deviant peer process in the amplification of problem behaviour. J. Adolesc. 2004, 27:515-530.
26. Dobzhansky T. Nothing in biology makes sense except in the light of evolution. Am. Biol. Teach. 1973, 35:125-129.
27. Dobzhansky T.G. Genetics and the Origin of Species 1951, Columbia University Press, New York.
28. Earleywine M. Understanding Marijuana: A New Look at the Scientific Evidence 2002, Oxford University Press, New York.
29. Ellgren M., Hurd Y.L., Franck J. Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence. Eur. J. Pharmacol. 2004, 497:205-213.
30. Ellis B.J., Garber J. Psychosocial antecedents of variation in girls' pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev. 2000, 71:485-501.
31. Erickson C.K., Wilcox R.E. Please, not "Addiction" in DSM-V. Am. J. Psychiatry 2006, 163:2015-2016. author reply 2016-2017.
32. Falconer D.S. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann. Hum. Genet. 1965, 29:51-76.
33. Feynman R.P. "Surely You're Joking, Mr. Feynman!" Adventures of a Curious Character 1985, W.W. Norton and Company, New York.
34. Furr-Holden C.D., Ialongo N.S., Anthony J.C., Petras H., Kellam S.G. Developmentally inspired drug prevention: middle school outcomes in a school-based randomized prevention trial. Drug Alcohol Depend. 2004, 73:149-158.
35. Ge X., Conger R.D., Elder G.H. Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev. 1996, 67:3386-3400.
36. Giorgetti M., Hotsenpiller G., Froestl W., Wolf M.E. In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment. Neuroscience 2002, 109:585-595.
37. Golub A., Johnson B. Substance use progression and hard drug use in inner city New York. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, 90-112. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
38. Gorenstein E.E., Newman J.P. Disinhibitory psychopathology: a new perspective and a model for research. Psychol. Rev. 1980, 87:301-315.
39. Goudreau J.L., Wagner E.J., Lookingland K.J., Moore K.E. gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity. J. Pharmacol. Exp. Ther. 1994, 271:1000-1006.
40. Graber J.A., Seeley J.R., Brooks-Gunn J., Lewinsohn P.M. Is pubertal timing associated with psychopathology in young adulthood. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:718-726.
41. Grunberg N.E., Faraday M.M. The value of animal models to examine the Gateway Hypothesis. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, 289-317. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
42. Guo G. Genetic similarity shared by best friends among adolescents. Twin Res. Hum. Genet. 2006, 9:113-121.
43. Hamilton W.D. The genetical evolution of social behaviour. I. J. Theor. Biol. 1964, 7:1-16.
44. Han C., McGue M.K., Iacono W.G. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 1999, 94:981-993.
45. Harrison J.E. Prolegomena to the Study of Greek Religion 1903, Cambridge at the University Press, Cambridge.
46. Hicks B.M., Blonigen D.M., Kramer M.D., Krueger R.F., Patrick C.J., Iacono W.G., McGue M. Gender differences and developmental change in externalizing disorders from late adolescence to early adulthood: a longitudinal twin study. J. Abnorm. Psychol. 2007, 116:433-447.
47. Hughes D.D. Human Sacrifice in Ancient Greece 1991, Routledge, London, GBR.
48. Iacono W.G., Malone S.M., McGue M. Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu. Rev. Clin. Psychol. 2008, 4:325-348.
49. Insel T.R. Is social attachment an addictive disorder?. Physiol. Behav. 2003, 79:351-357.
50. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010, 65:768-779.
51. Insel T.R., Wang Z.X., Ferris C.F. Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J. Neurosci. 1994, 14:5381-5392.
52. Insel T.R., Young L.J. The neurobiology of attachment. Nat. Rev. Neurosci. 2001, 2:129-136.
53. Irons D.E., McGue M., Iacono W.G., Oetting W.S. Mendelian randomization: a novel test of the gateway hypothesis and models of gene-environment interplay. Dev. Psychopathol. 2007, 19:1181-1195.
54. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl.) 2010, 211:415-422.
55. Jessor R., Jessor S.L. Problem Behavior and Psychosocial Development: A Longitudinal Study of Youth 1977, Academic Press, New York.
56. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12:483-488.
57. Kalivas P.W., Duffy P., Eberhardt H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 1990, 253:858-866.
58. Kandel D. Stages in adolescent involvement in drug use. Science 1975, 190:912-914.
59. Kandel D., Yamaguchi K. Developmental Stages of Involvement in Substance Use, Sourcebook on Substance Abuse: Etiology, Epidemiology, Assessment, and Treatment 1999, Allyn and Bacon, Boston, pp. 50-74.
60. Kandel D.B. Examining the gateway hypothesis: stages and pathways of drug involvement. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, 3-15. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
61. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
62. Kandel D.B. Does marijuana use cause the use of other drugs?. JAMA 2003, 289:482-483.
63. Kandel D.B., Jessor R. The gateway hypothesis revisited. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, 365-372. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
64. Kandel D.B., Yamaguchi K. Stages of drug involvement in the U.S. population. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, 65-89. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
65. Kandel D.B., Yamaguchi K., Klein L.C. Testing the gateway hypothesis. Addiction 2006, 101:470-472. discussion 474-476.
66. Kelz M.B., Chen J., Carlezon W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor delta FosB in the brain controls sensitivity to cocaine. Nature 1999, 401:272-276.
67. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry 2003, 160:687-695.
68. Kendler K.S., Karkowski L.M., Neale M.C., Prescott C.A. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry 2000, 57:261-269.
69. Kendler K.S., Myers J., Prescott C.A. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch. Gen. Psychiatry 2007, 64:1313-1320.
70. Kessler R.C., Aguilar-Gaxiola S., Andrade L., Bijl R.B.G., Caraveo-Anduaga J.J., DeWit D.J., Kolody B., Merikangas K.R., Molnar B.E., Vega W.A., Walters E.E., Wittchen H.-U., Ustun T.B. Mental-substance comorbidities in the ICPE surveys. Psychiatr. Fennica 2001, 32:62-79.
71. Kirillova G.P., Vanyukov M.M., Gavaler J.S., Pajer K., Dunn M., Tarter R.E. Substance abuse in parents and their adolescent offspring: the role of sexual maturation and sensation seeking. J. Child Adolesc. Subst. Abuse 2001, 10:77-89.
72. Kirillova G.P., Vanyukov M.M., Kirisci L., Reynolds M. Physical maturation, peer environment, and the ontogenesis of substance use disorders. Psychiatry Res. 2008, 158:43-53.
73. Kirisci L., Tarter R., Mezzich A., Ridenour T., Reynolds M., Vanyukov M. Prediction of cannabis use disorder between boyhood and young adulthood: clarifying the phenotype and environtype. Am. J. Addict. 2009, 18:36-47.
74. Kirisci L., Tarter R.E., Vanyukov M., Martin C., Mezzich A., Brown S. Application of item response theory to quantify substance use disorder severity. Addict. Behav. 2006, 31:1035-1049.
75. Kirisci L., Vanyukov M., Dunn M., Tarter R. Item response theory modeling of substance use: an index based on 10 drug categories. Psychol. Addict. Behav. 2002, 16:290-298.
76. Kolb B., Gibb R., Robinson T.E. Brain plasticity and behavior. Curr. Direct Psychol. Sci. 2003, 12:1-4.
77. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 1996, 16:4231-4239.
78. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
79. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
80. Krueger R.F., Hicks B.M., Patrick C.J., Carlson S.R., Iacono W.G., McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J. Abnorm. Psychol. 2002, 111:411-424.
81. Krueger R.F., Markon K.E., Patrick C.J., Benning S.D., Kramer M.D. Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum. J. Abnorm. Psychol. 2007, 116:645-666.
82. Lende D.H., Smith E.O. Evolution meets biopsychosociality: an analysis of addictive behavior. Addiction 2002, 97:447-458.
83. Leshner A.I. Foreword. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis 2002, xiii. Cambridge University Press, Cambridge. D.B. Kandel (Ed.).
84. Li H.J., Ji C.Y., Wang W., Hu Y.H. A twin study for serum leptin, soluble leptin receptor, and free insulin-like growth factor-I in pubertal females. J. Clin. Endocrinol. Metab. 2005, 90:3659-3664.
85. Li M.D., Burmeister M. New insights into the genetics of addiction. Nat. Rev. Genet. 2009, 10:225-231.
86. Lidow M.S., Goldman-Rakic P.S., Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10218-10221.
87. Light K.C., Grewen K.M., Amico J.A., Boccia M., Brownley K.A., Johns J.M. Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy. Addict. Behav. 2004, 29:1541-1564.
88. Livingston, I., Doyle, J., Mangan, D., 2010. Stabbed hero dies as more than 20 people stroll past him. New York Post, April 24.
89. Mackesy-Amiti M.E., Fendrich M., Goldstein P.J. Sequence of drug use among serious drug users: typical vs atypical progression. Drug Alcohol Depend. 1997, 45:185-196.
90. Maher B.S., Vladimirov V.I., Latendresse S.J., Thiselton D.L., McNamee R., Kang M., Bigdeli T.B., Chen X., Riley B., Hettema J.M., Chilcoat H., Heidbreder C., Muglia P., Murrelle E.L., Dick D.M., Aliev F., Agrawal A., Edenberg H., Kramer J., Nurnberger J., Devlin B., Ferrell R.E., Kirillova G.P., Tarter R.E., Kendler K.S., Vanyukov M.M. The AVPR1A gene and substance use disorders: association, replication and functional evidence. Biol. Psychiatry 2011, 70:519-527.
91. Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. 2001, National Academy Press, Washington, DC. C.F. Manski, J.V. Pepper, C.V. Petrie (Eds.).
92. McClung C.A., Ulery P.G., Perrotti L.I., Zachariou V., Berton O., Nestler E.J. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 2004, 132:146-154.
93. Mealey L. The sociobiology of sociopathy: an integrated evolutionary model. Behav. Brain Sci. 1995, 18:523-599.
94. Mezzacappa E., Kindlon D., Earls F. Relations of age to cognitive and motivational elements of impulse control in boys with and without externalizing behavior problems. J. Abnorm. Child Psychol. 1999, 27:473-483.
95. Moffitt T.E. Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol. Rev. 1993, 100:674-701.
96. Moffitt T.E., Caspi A., Belsky J., Silva P.A. Childhood experience and the onset of menarche: a test of a sociobiological model. Child Dev. 1992, 63:47-58.
97. Morral A.R., McCaffrey D.F., Paddock S.M. Reassessing the marijuana gateway effect. Addiction 2002, 97:1493-1504.
98. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmuhl Y., Fischer D., Holsboer F., Wotjak C.T., Almeida O.F., Spengler D. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 2009, 12:1559-1566.
99. Must A., Naumova E.N., Phillips S.M., Blum M., Dawson-Hughes B., Rand W.M. Childhood overweight and maturational timing in the development of adult overweight and fatness: the Newton Girls Study and its follow-up. Pediatrics 2005, 116:620-627.
100. Nesse R.M., Berridge K.C. Psychoactive drug use in evolutionary perspective. Science 1997, 278:63-66.
101. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. 2001, 10:201-217.
102. O'Brien C.P., Volkow N., Li T.-K. What's in a word? Addiction versus dependence in DSM-V. Am. J. Psychiatry 2006, 163:764-765.
103. O'Connor T.G., Deater-Deckard K., Fulker D., Rutter M., Plomin R. Genotype-environment correlations in late childhood and early adolescence: antisocial behavioral problems and coercive parenting. Dev. Psychol. 1998, 34:970-981.
104. Panksepp J. Affective Neuroscience 1998, Oxford Univ. Press, New York.
105. Panksepp J., Knutson B., Burgdorf J. The role of brain emotional systems in addictions: a neuro-evolutionary perspective and new 'self-report' animal model. Addiction 2002, 97:459-469.
106. Peters J., Kalivas P.W., Quirk G.J. Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn. Mem. 2009, 16:279-288.
107. Petitclerc A., Boivin M., Dionne G., Pérusse D., Tremblay R.E. Genetic and environmental etiology of disregard for rules. Behav. Genet. 2011, 41:192-200.
108. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518.
109. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
110. Romieu P., Host L., Gobaille S., Sandner G., Aunis D., Zwiller J. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J. Neurosci. 2008, 28:9342-9348.
111. The Hygiene Hypothesis and Darwinian Medicine 2009, Birkhäuser Verlag AG, Basel. G.A.W. Rook (Ed.).
112. Ruble N.M., Turner W.L. A systemic analysis of the dynamics and organization of urban street gangs. Am. J. Fam. Ther. 2000, 28:117-132.
113. Sanchis-Segura C., Lopez-Atalaya J.P., Barco A. Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 2009, 34:2642-2654.
114. Scarr S., McCartney K. How people make their own environments: a theory of genotype greater than environment effects. Child Dev. 1983, 54:424-435.
115. Shepner J. Mate selection among second generation kibbutz adolescents and adults: incest avoidance and negative imprinting. Arch. Sex. Behav. 1971, 1:293-307.
116. Sherva R., Kranzler H.R., Yu Y., Logue M.W., Poling J., Arias A.J., Anton R.F., Oslin D., Farrer L.A., Gelernter J. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 2010, 35:1921-1931.
117. Smith W. Dictionary of Greek and Roman Antiquities 1898, John Murray, London.
118. Stice E., Presnell K., Bearman S.K. Relation of early menarche to depression, eating disorders, substance abuse, and comorbid psychopathology among adolescent girls. Dev. Psychol. 2001, 37:608-619.
119. Tan K.R., Brown M., Labouebe G., Yvon C., Creton C., Fritschy J.M., Rudolph U., Luscher C. Neural bases for addictive properties of benzodiazepines. Nature 2010, 463:769-774.
120. Tarter R., Vanyukov M., Giancola P., Dawes M., Blackson T., Mezzich A., Clark D.B. Etiology of early age onset substance use disorder: a maturational perspective. Dev. Psychopathol. 1999, 11:657-683.
121. Tarter R.E., Kirisci L., Mezzich A., Cornelius J.R., Pajer K., Vanyukov M., Gardner W., Blackson T., Clark D. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am. J. Psychiatry 2003, 160:1078-1085.
122. Tarter R.E., Vanyukov M. Alcoholism: a developmental disorder. J. Consult. Clin. Psychol. 1994, 62:1096-1107.
123. Tarter R.E., Vanyukov M., Kirisci L., Reynolds M., Clark D.B. Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. Am. J. Psychiatry 2006, 163:2134-2140.
124. Teicher M.H., Andersen S.L., Polcari A., Anderson C.M., Navalta C.P. Developmental neurobiology of childhood stress and trauma. Psychiatr. Clin. North Am. 2002, 25:397-426. vii-viii.
125. Teicher M.H., Krenzel E., Thompson A.P., Andersen S.L. Dopamine receptor pruning during the peripubertal period is not attenuated by NMDA receptor antagonism in rat. Neurosci. Lett. 2003, 339:169-171.
126. Tremblay L., Frigon J.Y. Precocious puberty in adolescent girls: a biomarker of later psychosocial adjustment problems. Child Psychiatry Hum. Dev. 2005, 36:73-94.
127. Tullis L.M., Dupont R., Frost-Pineda K., Gold M.S. Marijuana and tobacco: a major connection. J. Addict. Dis. 2003, 22:51-62.
128. U.S. Dept. of Health and Human Services, S.A.M.H.S.A., Office of Applied Studies, 2008. National Survey on Drug Use and Health, 2007 [Computer file]. ICPSR23782-v1. Research Triangle Institute [producer], Research Triangle Park, NC.
129. Uslaner J., Badiani A., Day H.E., Watson S.J., Akil H., Robinson T.E. Environmental context modulates the ability of cocaine and amphetamine to induce c-Fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res. 2001, 920:106-116.
130. Vanyukov M.M. Evolution, genes, and environment-neurobiological outcomes. The Science, Treatment, and Prevention of Antisocial Behaviors: Application to the Criminal Justice System 2004, Civic Research Institute, Kingston, NJ, pp. 4-1-4-29. D.H. Fishbein (Ed.).
131. Vanyukov M.M., Kirisci L., Moss L., Tarter R.E., Reynolds M.D., Maher B.S., Kirillova G.P., Ridenour T., Clark D.B. Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. Behav. Genet. 2009, 39:233-244.
132. Vanyukov M.M., Kirisci L., Tarter R.E., Simkevitz H.F., Kirillova G.P., Maher B.S., Clark D.B. Liability to substance use disorders: 2. A measurement approach. Neurosci. Biobehav. Rev. 2003, 27:517-526.
133. Vanyukov M.M., Maher B.S., Devlin B., Kirillova G.P., Kirisci L., Yu L.M., Ferrell R.E. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Psychiatr. Genet. 2007, 17:323-332.
134. Vanyukov M.M., Moss H.B., Tarter R.E. Assortment for the liability to substance abuse and personality traits. Ann. N. Y. Acad. Sci. 1994, 708:102-107.
135. Vanyukov M.M., Neale M.C., Moss H.B., Tarter R.E. Mating assortment and the liability to substance abuse. Drug Alcohol Depend. 1996, 42:1-10.
136. Vanyukov M.M., Tarter R.E. Genetic studies of substance abuse. Drug Alcohol Depend. 2000, 59:101-123.
137. Vanyukov M.M., Tarter R.E., Kirisci L., Kirillova G.P., Maher B.S., Clark D.B. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci. Biobehav. Rev. 2003, 27:507-515.
138. Walden B., McGue M., Lacono W.G., Burt S.A., Elkins I. Identifying shared environmental contributions to early substance use: the respective roles of peers and parents. J. Abnorm. Psychol. 2004, 113:440-450.
139. Walker E.F., Sabuwalla Z., Huot R. Pubertal neuromaturation, stress sensitivity, and psychopathology. Dev. Psychopathol. 2004, 16:807-824.
140. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002, 110:903-910.
141. Warner L.A., Kessler R.C., Hughes M., Anthony J.C., Nelson C.B. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:219-229.
142. Wilson E.O. Sociobiology: The New Synthesis 2000, The Belknap Press of Harvard University Press, Cambridge, MA.
143. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 1998, 51:13-22.
144. Wu L.T., Pan J.J., Blazer D.G., Tai B., Stitzer M.L., Brooner R.K., Woody G.E., Patkar A.A., Blaine J.D. An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J. Stud. Alcohol Drugs 2009, 70:414-425.
145. Young S.E., Stallings M.C., Corley R.P., Krauter K.S., Hewitt J.K. Genetic and environmental influences on behavioral disinhibition. Am. J. Med. Genet. 2000, 96:684-695.